Microbiome Biomarkers: One Step Closer in NAFLD Cirrhosis
Tracey G. Simon, Andrew T. Chan, Curtis Huttenhower – 29 November 2020
Tracey G. Simon, Andrew T. Chan, Curtis Huttenhower – 29 November 2020
Philip R. Spradling, Yuna Zhong, Anne C. Moorman, Loralee B. Rupp, Mei Lu, Stuart C. Gordon, Eyasu H. Teshale, Mark A. Schmidt, Yihe G. Daida, Joseph A. Boscarino, for the Chronic Hepatitis Cohort Study (CHeCS) Investigators – 29 November 2020 – There are limited data examining the relationship between psychosocial factors and receipt of direct‐acting antiviral (DAA) treatment among patients with hepatitis C in large health care organizations in the United States. We therefore sought to determine whether such factors were associated with DAA initiation.
Morteza Hafezi, Meiyin Lin, Adeline Chia, Alicia Chua, Zi Zong Ho, Royce Fam, Damien Tan, Joey Aw, Andrea Pavesi, Thinesh Lee Krishnamoorthy, Wan Cheng Chow, Wenjie Chen, Qi Zhang, Lu‐En Wai, Sarene Koh, Anthony T. Tan, Antonio Bertoletti – 29 November 2020
Hye‐Mee Kwon, Young‐Jin Moon, Kyoung‐Sun Kim, Won‐Jung Shin, In‐Young Huh, In‐Gu Jun, Jun‐Gol Song, Gyu‐Sam Hwang – 28 November 2020
Diana Apetauerova, Peter Hildebrand, Stephanie Scala, Janet W. Zani, LeeAnne Lipert, Erin Clark, Tanya Fennell, Fredric D. Gordon – 26 November 2020 – Acquired hepatocerebral degeneration refers to a neurological syndrome consisting of various movement disorders and cognitive impairment in advanced liver cirrhosis or portosystemic shunt. Neurological signs and symptoms may be attributed to the accumulation of toxic substances in the brain. The most common neurological presentation of this is parkinsonism.
Gabriela Hernandez‐Meza, Johann Felden, Edgar E. Gonzalez‐Kozlova, Teresa Garcia‐Lezana, Judit Peix, Anna Portela, Amanda J. Craig, Sergi Sayols, Myron Schwartz, Bojan Losic, Vincenzo Mazzaferro, Manel Esteller, Josep M. Llovet, Augusto Villanueva – 25 November 2020
Ville Männistö, Dorota Kaminska, Pirjo Käkelä, Mikko Neuvonen, Mikko Niemi, Marcus Alvarez, Päivi Pajukanta, Stefano Romeo, Max Nieuwdorp, Albert.K. Groen, Jussi Pihlajamäki – 25 November 2020 – The protein phosphatase 1 regulatory subunit 3B (PPP1R3B) gene is a target of farnesoid X receptor (FXR), which is a major regulator of bile acid metabolism. Both PPP1R3B and FXR have been suggested to take part in glycogen metabolism, which may explain the association of PPP1R3B gene variants with altered hepatic computed tomography attenuation.
Michel Rayar, Jean‐Marie Beaurepaire, Emma Bajeux, Stéphanie Hamonic, Thomas Renard, Clara Locher, Véronique Desfourneaux, Aude Merdrignac, Damien Bergeat, Mohamed Lakehal, Laurent Sulpice, Pauline Houssel‐Debry, Caroline Jezequel, Christophe Camus, Edouard Bardou‐Jacquet, Bernard Meunier – 25 November 2020 – Few studies have evaluated the efficacy or the cost of hypothermic oxygenated perfusion (HOPE) in the conservation of extended criteria donor (ECD) grafts from donation after brain death (DBD) donors during liver transplantation (LT).
Christophe Cassinotto, Jérome Boursier, Anita Paisant, Boris Guiu, Marie Irles‐Depe, Clémence Canivet, Christophe Aube, Victor Ledinghen – 24 November 2020
Xin Hou, Shi Yin, Ruixue Ren, Siqi Liu, Liang Yong, Yuxiao Liu, Yu Li, Ming‐Hua Zheng, George Kunos, Bin Gao, Hua Wang – 24 November 2020